Last reviewed · How we verify
Ginkgolides Meglumine Injection — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Ginkgolides Meglumine Injection (Ginkgolides Meglumine Injection) — Jiangsu Kanion Pharmaceutical Co., Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ginkgolides Meglumine Injection TARGET | Ginkgolides Meglumine Injection | Jiangsu Kanion Pharmaceutical Co., Ltd | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ginkgolides Meglumine Injection CI watch — RSS
- Ginkgolides Meglumine Injection CI watch — Atom
- Ginkgolides Meglumine Injection CI watch — JSON
- Ginkgolides Meglumine Injection alone — RSS
Cite this brief
Drug Landscape (2026). Ginkgolides Meglumine Injection — Competitive Intelligence Brief. https://druglandscape.com/ci/ginkgolides-meglumine-injection. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab